All data are based on the daily closing price as of February 16, 2026
b
BioNote
377740.KO
4.02 USD
-0.02
-0.50%
Overview
Last close
4.02 usd
Market cap
405.29M usd
52 week high
4.47 usd
52 week low
2.83 usd
Target price
3.96 usd
Valuation
P/E
N/A
Forward P/E
N/A
Price/Sales
5.0856
Price/Book Value
0.3438
Enterprise Value
166.04M usd
EV/Revenue
2.0752
EV/EBITDA
1.6756
Key financials
Revenue TTM
80.01M usd
Gross Profit TTM
44.48M usd
EBITDA TTM
18.94M usd
Earnings per Share
N/A usd
Dividend
0.14 usd
Total assets
1.33B usd
Net debt
N/A usd
About
BioNote, Inc., manufactures and sells in-vitro diagnostic animal medicines in South Korea. It offers animal diagnostics products, such as fluorescence immunoassay, molecular diagnostics, clinical biochemistry, rapid immunoassay, and enzyme-linked immunosorbent assay products. The company also provides bio-content products, including rapid immunoassay for humans, human intermediate goods, and bio-contents reagents. In addition, it engages in the production and sell of medical devices. BioNote, Inc. was founded in 2003 and is headquartered in Hwaseong-si, South Korea.